Second Generation Long-Acting Injectable Antipsychotics in Africa: About a Case

INTRODUCTION: Schizophrenia affects people worldwide. In Europe, the advantages of second-generation and long-acting injectable antipsychotics (SG-LAIs) are known and used, supported by scientific evidence. However, somewhere there is limited evidence on this topic. OBJECTIVES: Highlight the improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvañ, J., Nguepy-Keubo, F. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479505/
http://dx.doi.org/10.1192/j.eurpsy.2023.1737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479505/
http://dx.doi.org/10.1192/j.eurpsy.2023.1737

Ejemplares similares